{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T16:24:45Z","timestamp":1777307085654,"version":"3.51.4"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T00:00:00Z","timestamp":1600646400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T00:00:00Z","timestamp":1600646400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ir J Med Sci"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s11845-020-02366-5","type":"journal-article","created":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T09:03:27Z","timestamp":1600679007000},"page":"631-638","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Interleukin-1\u03b2, interleukin-6, and interleukin-17A as indicators reflecting clinical response to celecoxib in ankylosing spondylitis patients"],"prefix":"10.1007","volume":"190","author":[{"given":"Yang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2268-9211","authenticated-orcid":false,"given":"Chao","family":"Ning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huijie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingjie","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fulai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yayun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,21]]},"reference":[{"issue":"9570","key":"2366_CR1","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/S0140-6736(07)60635-7","volume":"369","author":"J Braun","year":"2007","unstructured":"Braun J, Sieper J (2007) Ankylosing spondylitis. Lancet 369(9570):1379\u20131390","journal-title":"Lancet"},{"issue":"7","key":"2366_CR2","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/nrrheum.2017.92","volume":"13","author":"K Bidad","year":"2017","unstructured":"Bidad K, Gracey E, Hemington KS et al (2017) Pain in ankylosing spondylitis: a neuro-immune collaboration. Nat Rev Rheumatol 13(7):410\u2013420","journal-title":"Nat Rev Rheumatol"},{"key":"2366_CR3","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.curtheres.2014.08.002","volume":"76","author":"F Huang","year":"2014","unstructured":"Huang F, Gu J, Liu Y et al (2014) Efficacy and safety of celecoxib in Chinese patients with ankylosing spondylitis: a 6-week randomized, double-blinded study with 6-week open-label extension treatment. Curr Ther Res Clin Exp 76:126\u2013133","journal-title":"Curr Ther Res Clin Exp"},{"issue":"7","key":"2366_CR4","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrrheum.2010.79","volume":"6","author":"LS Tam","year":"2010","unstructured":"Tam LS, Gu J, Yu D (2010) Pathogenesis of ankylosing spondylitis. Nat Rev Rheumatol 6(7):399\u2013405","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"2366_CR5","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1517\/14740338.7.4.401","volume":"7","author":"DA Poddubnyy","year":"2008","unstructured":"Poddubnyy DA, Song IH, Sieper J (2008) The safety of celecoxib in ankylosing spondylitis treatment. Expert Opin Drug Saf 7(4):401\u2013409","journal-title":"Expert Opin Drug Saf"},{"issue":"18","key":"2366_CR6","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.2165\/11208240-000000000-00000","volume":"71","author":"PL McCormack","year":"2011","unstructured":"McCormack PL (2011) Celecoxib: a review of its use for symptomatic relief in the treatment of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis. Drugs 71(18):2457\u20132489","journal-title":"Drugs"},{"issue":"7\u20138","key":"2366_CR7","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s10354-008-0521-3","volume":"158","author":"S van der Linden","year":"2008","unstructured":"van der Linden S (2008) Issues in the treatment of ankylosing spondylitis with non-steroidal anti-inflammatory drugs. Wien Med Wochenschr 158(7\u20138):195\u2013199","journal-title":"Wien Med Wochenschr"},{"issue":"2","key":"2366_CR8","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3109\/03009742.2014.956142","volume":"44","author":"SH Sveaas","year":"2015","unstructured":"Sveaas SH, Berg IJ, Provan SA et al (2015) Circulating levels of inflammatory cytokines and cytokine receptors in patients with ankylosing spondylitis: a cross-sectional comparative study. Scand J Rheumatol 44(2):118\u2013124","journal-title":"Scand J Rheumatol"},{"issue":"3","key":"2366_CR9","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1111\/j.1600-0765.2011.01448.x","volume":"47","author":"U Sezer","year":"2012","unstructured":"Sezer U, Erciyas K, Pehlivan Y et al (2012) Serum cytokine levels and periodontal parameters in ankylosing spondylitis. J Periodontal Res 47(3):396\u2013401","journal-title":"J Periodontal Res"},{"key":"2366_CR10","doi-asserted-by":"crossref","unstructured":"Wen JT, Zhang DH, Fang PF et al (2017) Role of Th1\/Th2 cytokines in the diagnosis and prognostic evaluation of ankylosing spondylitis. Genet Mol Res 16(1)","DOI":"10.4238\/gmr16019322"},{"issue":"4","key":"2366_CR11","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1139\/bcb-2017-0267","volume":"96","author":"Y Yan","year":"2018","unstructured":"Yan Y, Guo TM, Zhu C (2018) Effects of nonsteroidal anti-inflammatory drugs on serum proinflammatory cytokines in the treatment of ankylosing spondylitis. Biochem Cell Biol 96(4):450\u2013456","journal-title":"Biochem Cell Biol"},{"key":"2366_CR12","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1016\/j.biopha.2017.08.093","volume":"95","author":"JE Pan","year":"2017","unstructured":"Pan JE, Xiong FL, Chen G et al (2017) Aquaporin-1 expression as an indicator in evaluating the efficacy of meloxicam in the treatment of ankylosing spondylitis: a comparative study. Biomed Pharmacother 95:1549\u20131555","journal-title":"Biomed Pharmacother"},{"issue":"Suppl 2","key":"2366_CR13","doi-asserted-by":"publisher","first-page":"ii1","DOI":"10.1136\/ard.2008.104018","volume":"68","author":"J Sieper","year":"2009","unstructured":"Sieper J, Rudwaleit M, Baraliakos X et al (2009) The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis. Ann Rheum Dis 68(Suppl 2):ii1\u2013i44","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"2366_CR14","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1002\/1529-0131(200108)44:8<1876::AID-ART326>3.0.CO;2-F","volume":"44","author":"JJ Anderson","year":"2001","unstructured":"Anderson JJ, Baron G, van der Heijde D et al (2001) Ankylosing spondylitis assessment group preliminary definition of short-term improvement in ankylosing spondylitis. Arthritis Rheum 44(8):1876\u20131886","journal-title":"Arthritis Rheum"},{"issue":"1","key":"2366_CR15","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1136\/ard.2003.006916","volume":"63","author":"MA Stone","year":"2004","unstructured":"Stone MA, Payne U, Pacheco-Tena C et al (2004) Cytokine correlates of clinical response patterns to infliximab treatment of ankylosing spondylitis. Ann Rheum Dis 63(1):84\u201387","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"2366_CR16","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s002960050119","volume":"19","author":"A Falkenbach","year":"2000","unstructured":"Falkenbach A, Herold M, Wigand R (2000) Interleukin-6 serum concentration in ankylosing spondylitis: a reliable predictor of disease progression in the subsequent year? Rheumatol Int 19(4):149\u2013151","journal-title":"Rheumatol Int"}],"container-title":["Irish Journal of Medical Science (1971 -)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-020-02366-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11845-020-02366-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-020-02366-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T23:56:58Z","timestamp":1632182218000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11845-020-02366-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,21]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["2366"],"URL":"https:\/\/doi.org\/10.1007\/s11845-020-02366-5","relation":{},"ISSN":["0021-1265","1863-4362"],"issn-type":[{"value":"0021-1265","type":"print"},{"value":"1863-4362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,21]]},"assertion":[{"value":"31 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The approval of this study was obtained from the Institutional Review Board of our hospital. Written informed consents were collected from all enrolled patients.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}